Neurophysiologic evidence for a central sensitization in patients with fibromyalgia

被引:427
作者
Desmeules, JA [1 ]
Cedraschi, C [1 ]
Rapiti, E [1 ]
Baumgartner, E [1 ]
Finckh, A [1 ]
Cohen, P [1 ]
Dayer, P [1 ]
Vischer, TL [1 ]
机构
[1] Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, CH-1211 Geneva 14, Switzerland
来源
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 05期
关键词
D O I
10.1002/art.10893
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine whether abnormalities of peripheral and central nociceptive sensory input processing exist outside areas of spontaneous pain in patients with fibromyalgia (FM) as compared with controls, by using quantitative sensory testing (QST) and a neurophysiologic paradigm independent from subjective reports. Methods. A total of 164 outpatients with FM who were attending a self-management program were invited to participate in the study. Data for 85 patients were available and were compared with those for 40 non-FM controls matched for age,and sex. QST was performed using thermal, mechanical, and electrical stimuli at locations of nonspontaneous pain. Pain assessment was 2-fold and included use of subjective scales and the spinal nociceptive flexion reflex (NFR), a specific physiologic correlate for the objective evaluation of central nociceptive pathways. Questionnaires regarding quality of life and the impact of FM were available. Results. Participants were mainly middle-aged women, with a mean disease duration of 8 years. Between-group differences were significant for neurophysiologic, clinical, and quality of life measures. In patients with FM, peripheral QST showed significantly altered cold and heat pain thresholds, and tolerance to cold pain was radically reduced. The median NFR threshold in patients with FM (22.7 mA [range 17.5-31.7]) was significantly decreased compared with that in controls (33 mA [range 28.1-41]). A cutoff value of <27.6 mA for NFR provided sensitivity of 73% and specificity of 80% for detecting central allodynia in the setting of FM. Conclusion. Our results strongly, although indirectly, point to a state of central hyperexcitability of the nociceptive system in patients with FM. The NFR can be used to assess central allodynia in FM. It may also help discriminate patients who may benefit from use of centrally acting analgesics.
引用
收藏
页码:1420 / 1429
页数:10
相关论文
共 81 条
[1]   ELECTROPHYSIOLOGICAL AND PSYCHOPHYSICAL QUANTIFICATION OF TEMPORAL SUMMATION IN THE HUMAN NOCICEPTIVE SYSTEM [J].
ARENDTNIELSEN, L ;
BRENNUM, J ;
SINDRUP, S ;
BAK, P .
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY, 1994, 68 (03) :266-273
[2]   THE EFFECT OF INTRAVENOUS LIDOCAINE ON NOCICEPTIVE PROCESSING IN DIABETIC NEUROPATHY [J].
BACH, FW ;
JENSEN, TS ;
KASTRUP, J ;
STIGSBY, B ;
DEJGARD, A .
PAIN, 1990, 40 (01) :29-34
[3]   HUMAN SPINAL REFLEXES AND ATTENTION LEVELS [J].
BATHIEN, N .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1971, 30 (01) :32-&
[4]   A six year prospective study of a cohort of patients with fibromyalgia [J].
Baumgartner, E ;
Finckh, A ;
Cedraschi, C ;
Vischer, TL .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (07) :644-645
[5]   Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia [J].
Berglund, B ;
Harju, EL ;
Kosek, E ;
Lindblom, U .
PAIN, 2002, 96 (1-2) :177-187
[6]   Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers [J].
Bossard, AE ;
Guirimand, F ;
Fletcher, D ;
Gaude-Joindreau, V ;
Chauvin, M ;
Bouhassira, D .
PAIN, 2002, 98 (1-2) :47-57
[7]   DIFFUSE NOXIOUS INHIBITORY CONTROLS IN HUMANS - A NEUROPHYSIOLOGICAL INVESTIGATION OF A PATIENT WITH A FORM OF BROWN-SEQUARD SYNDROME [J].
BOUHASSIRA, D ;
LEBARS, D ;
BOLGERT, F ;
LAPLANE, D ;
WILLER, JC .
ANNALS OF NEUROLOGY, 1993, 34 (04) :536-543
[8]   STUDY OF EXPERIMENTAL PAIN MEASURES AND NOCICEPTIVE REFLEX IN CHRONIC PAIN PATIENTS AND NORMAL SUBJECTS [J].
BOUREAU, F ;
LUU, M ;
DOUBRERE, JF .
PAIN, 1991, 44 (02) :131-138
[9]  
BRAMI A, 1987, BRAIN, V110, P1497
[10]  
BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728